SB5 (BIIB606)- adalimumab-bwwd injection, solution 
Catalent Indiana, LLC

----------

LBL168-100-002LBL168-100-002

SB5 (BIIB606) 
adalimumab-bwwd injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:61434-005
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ADALIMUMAB-BWWD (UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842) ADALIMUMAB-BWWD40 mg  in 0.8 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:61434-005-001280 in 1 CASE08/27/2017
10.8 mL in 1 SYRINGE, GLASS; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
export only08/27/2017
Labeler - Catalent Indiana, LLC (172209277)
Establishment
NameAddressID/FEIBusiness Operations
Biogen MA Inc.841087823api manufacture(61434-005)

Revised: 9/2022
Document Id: 8390e6a6-e338-439c-ba70-5246ecf41040
Set id: 002d3e04-7558-4e22-85bb-09e30566bd0b
Version: 1
Effective Time: 20220921
 
Catalent Indiana, LLC